BACKGROUND: In Huntington's disease (HD), the cerebral cortex is involved early in the disease process. The study of cortical excitability can therefore contribute to understanding HD pathophysiology. METHODS: With transcranial magnetic stimulation (TMS) we examined motor cortex excitability in 8 premanifest HD gene carriers, 8 very early symptomatic HD patients, and 22 healthy control subjects. Electrophysiological measures were correlated with the clinical stage of HD to identify motor cortical dysfunction before overt clinical disease onset. RESULTS: Premanifest and early manifest HD patients had higher resting and active motor cortex thresholds than control subjects (p = .024). At rest, recruitment of motor evoked potentials was more gradual in both patient groups than in control subjects (p = .001). When active, recruitment and the duration of the cortical silent period were similar in all groups. There was a tendency for short interval intra-cortical inhibition to have a higher threshold in all patients taken together but not in each group separately. Short latency afferent inhibition (SAI) was reduced in early manifest patients compared with control subjects and premanifest patients (p < .001) and in contrast to all other measures was inversely associated with estimated time to onset (p = .013, adjusted R(2) = .32) and the Unified Huntington's Disease Rating Scale motor score (p = .001, adjusted R(2) = .5). A combination of age, CAG repeat length, and SAI strongly predicted the Unified Huntington's Disease Rating Scale motor score (p = .001, adjusted R(2) = .68). CONCLUSIONS: Our findings add to the evidence for early cortical involvement in HD possibly before HD signs appear.
BACKGROUND: In Huntington's disease (HD), the cerebral cortex is involved early in the disease process. The study of cortical excitability can therefore contribute to understanding HD pathophysiology. METHODS: With transcranial magnetic stimulation (TMS) we examined motor cortex excitability in 8 premanifest HD gene carriers, 8 very early symptomatic HDpatients, and 22 healthy control subjects. Electrophysiological measures were correlated with the clinical stage of HD to identify motor cortical dysfunction before overt clinical disease onset. RESULTS: Premanifest and early manifest HDpatients had higher resting and active motor cortex thresholds than control subjects (p = .024). At rest, recruitment of motor evoked potentials was more gradual in both patient groups than in control subjects (p = .001). When active, recruitment and the duration of the cortical silent period were similar in all groups. There was a tendency for short interval intra-cortical inhibition to have a higher threshold in all patients taken together but not in each group separately. Short latency afferent inhibition (SAI) was reduced in early manifest patients compared with control subjects and premanifest patients (p < .001) and in contrast to all other measures was inversely associated with estimated time to onset (p = .013, adjusted R(2) = .32) and the Unified Huntington's Disease Rating Scale motor score (p = .001, adjusted R(2) = .5). A combination of age, CAG repeat length, and SAI strongly predicted the Unified Huntington's Disease Rating Scale motor score (p = .001, adjusted R(2) = .68). CONCLUSIONS: Our findings add to the evidence for early cortical involvement in HD possibly before HD signs appear.
Authors: E Gómez-Tortosa; M E MacDonald; J C Friend; S A Taylor; L J Weiler; L A Cupples; J Srinidhi; J F Gusella; E D Bird; J P Vonsattel; R H Myers Journal: Ann Neurol Date: 2001-01 Impact factor: 10.422
Authors: Vincenzo Di Lazzaro; A Oliviero; P A Tonali; C Marra; A Daniele; P Profice; E Saturno; F Pilato; C Masullo; J C Rothwell Journal: Neurology Date: 2002-08-13 Impact factor: 9.910
Authors: V Di Lazzaro; A Oliviero; P Profice; M A Pennisi; S Di Giovanni; G Zito; P Tonali; J C Rothwell Journal: Exp Brain Res Date: 2000-12 Impact factor: 1.972
Authors: N Modugno; A Currà; M Giovannelli; A Priori; F Squitieri; S Ruggieri; M Manfredi; A Berardelli Journal: Clin Neurophysiol Date: 2001-08 Impact factor: 3.708
Authors: H Tokimura; V Di Lazzaro; Y Tokimura; A Oliviero; P Profice; A Insola; P Mazzone; P Tonali; J C Rothwell Journal: J Physiol Date: 2000-03-01 Impact factor: 5.182
Authors: J M Vetter; T Jehle; J Heinemeyer; P Franz; P F Behrens; R Jackisch; G B Landwehrmeyer; T J Feuerstein Journal: J Neurochem Date: 2003-05 Impact factor: 5.372
Authors: H D Rosas; W J Koroshetz; Y I Chen; C Skeuse; M Vangel; M E Cudkowicz; K Caplan; K Marek; L J Seidman; N Makris; B G Jenkins; J M Goldstein Journal: Neurology Date: 2003-05-27 Impact factor: 9.910
Authors: Paolo Calabresi; Antonio Pisani; John Rothwell; Veronica Ghiglieri; Josè A Obeso; Barbara Picconi Journal: Nat Neurosci Date: 2016-06-28 Impact factor: 24.884
Authors: Carlos Cepeda; Katerina D Oikonomou; Damian Cummings; Joshua Barry; Vannah-Wila Yazon; Dickson T Chen; Janelle Asai; Christopher K Williams; Harry V Vinters Journal: J Neurosci Res Date: 2019-07-28 Impact factor: 4.164
Authors: Robert Christian Wolf; Georg Grön; Fabio Sambataro; Nenad Vasic; Nadine Donata Wolf; Philipp Arthur Thomann; Carsten Saft; G Bernhard Landwehrmeyer; Michael Orth Journal: Hum Brain Mapp Date: 2011-08-25 Impact factor: 5.038